Huang Junjie, Chan Sze Chai, Ko Samantha, Tong Ellen, Cheung Clement S K, Wong Wing Nam, Cheung Ngai Tseung, Wong Martin C S
JC School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
Centre for Health Education and Health Promotion, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
NPJ Digit Med. 2023 Apr 13;6(1):67. doi: 10.1038/s41746-023-00807-w.
In January 2021, the eHealth App was launched in Hong Kong by the Hong Kong government to support the Electronic Health Record Sharing System (eHRSS). A Health Management Module in the eHealth App introduced new functions to record blood pressure, blood sugar, and heart rate, and downloading and sharing records. This study aims to compare the level of glycaemic control between users of the eHealth App and non-users. Type 2 diabetes patients who have joined the eHRSS with existing haemoglobin A1c (HbA1c) level records are recruited. Correlations between predictors and optimal HbA1c control (<7%) are examined using logistic regression analyses. A total of 109,823 participants are included, with 76,356 non-users of eHealth App, 31,723 users of eHealth App, and 1744 users of the eHealth Management Module together with the App. We collect HbA1c values from Jan 2021 to May 2022, and they are 6 months after the use of the App on average. Users of the eHealth Management Module are found to have more optimal HbA1c levels across all subgroups, with the strongest effect observed in younger females (aOR = 1.66, 95% CI = 1.27-2.17). eHealth App usage is also positively associated with optimal HbA1c levels, particularly amongst younger females (aOR = 1.17, 95% CI = 1.08-1.26). Overall, users of eHealth App and eHealth Management Module demonstrate more optimal HbA1c levels when compared with non-users, particularly among younger adults and females. These findings support its potential adoption in diabetes patients. Future studies should examine the impact of eHealth interventions on other clinical targets and diabetes complications.
2021年1月，香港政府在香港推出了电子健康应用程序，以支持电子健康记录共享系统（eHRSS）。该电子健康应用程序中的健康管理模块引入了记录血压、血糖和心率以及下载和共享记录的新功能。本研究旨在比较电子健康应用程序用户和非用户之间的血糖控制水平。招募已加入电子健康记录共享系统且有现有糖化血红蛋白（HbA1c）水平记录的2型糖尿病患者。使用逻辑回归分析检查预测因素与最佳HbA1c控制（<7%）之间的相关性。总共纳入了109,823名参与者，其中76,356名非电子健康应用程序用户，31,723名电子健康应用程序用户，以及1744名同时使用电子健康管理模块和该应用程序的用户。我们收集了2021年1月至2022年5月的HbA1c值，平均是在使用该应用程序6个月后。发现在所有亚组中，使用电子健康管理模块的用户具有更优的HbA1c水平，在年轻女性中观察到的效果最强（调整后比值比[aOR]=1.66，95%置信区间[CI]=1.27-2.17）。使用电子健康应用程序也与更优的HbA1c水平呈正相关，尤其是在年轻女性中（aOR=1.17，95%CI=1.08-1.26）。总体而言，与非用户相比，电子健康应用程序和电子健康管理模块的用户表现出更优的HbA1c水平，尤其是在年轻人和女性中。这些发现支持了其在糖尿病患者中的潜在应用。未来的研究应考察电子健康干预对其他临床指标和糖尿病并发症的影响。
